Michael R. Bristow
Heart Failure & Transplant
University of Colorado Anschutz Medical Campus
About
Michael R. Bristow works in Heart Failure & Transplant affiliated with University of Colorado Anschutz Medical Campus.
Michael R. Bristow was a Professor of Medicine in Cardiology at the University of Colorado Anschutz Medical Campus and Director of the Section of Pharmacogenomics there. He served as President and Chief Executive Officer of ARCA biopharma, a company he founded to develop genetically-targeted therapies for heart failure. He previously headed the Division of Cardiology at the University of Colorado from 1991 to 2004 and co-founded the University of Colorado Cardiovascular Institute.
Research focus
Heart Failure PharmacotherapyCardiac TransplantationPharmacogenomics in Cardiovascular DiseaseBeta-Adrenergic Receptor SignalingCardiomyopathy Management
Impact
585 pubs · 58,515 cites · h-index 109
Training
MD
University of Illinois-Chicago
1970
PhD in Pharmacology
University of Illinois-Chicago
1971
BS in Veterinary Science
University of Illinois
1966
Affiliations
Work Experience
Professor of Medicine (Cardiology)
University of Colorado Anschutz Medical Campus · 1991 - 2025
President and Chief Executive Officer
ARCA Biopharma · 2004 - 2024
Head of the Division of Cardiology
University of Colorado · 1991 - 2004
Faculty Member, Division of Cardiology
University of Utah · 1984 - 1991
Project Leader, Heart and Lung Transplantation Program
Stanford University · 1979 - 1984